Back to Search
Start Over
FEIBA: A Prohemostatic Agent.
FEIBA: A Prohemostatic Agent.
- Source :
-
Seminars in Thrombosis & Hemostasis . Apr2012, Vol. 38 Issue 3, p265-267. 3p. - Publication Year :
- 2012
-
Abstract
- Factor eight inhibitor bypassing activity (FEIBA), Anti-Inhibitor Coagulation Complex has been used for over 30 years in hemophiliac patients with inhibitors. The history of its use is reviewed here, including issues related to thrombosis, efficacy, and comparison to alternative bypassing agents. The need for surrogate assays to monitor effective hemostasis with the use of FEIBA remains. [ABSTRACT FROM AUTHOR]
- Subjects :
- *FIBRINOGEN
*HEMOSTATICS
*HEMATOLOGIC agents
*CARDIAC surgery
*HEMOSTASIS
Subjects
Details
- Language :
- English
- ISSN :
- 00946176
- Volume :
- 38
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Seminars in Thrombosis & Hemostasis
- Publication Type :
- Academic Journal
- Accession number :
- 74310983
- Full Text :
- https://doi.org/10.1055/s-0032-1309286